JP2012525358A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012525358A5 JP2012525358A5 JP2012507765A JP2012507765A JP2012525358A5 JP 2012525358 A5 JP2012525358 A5 JP 2012525358A5 JP 2012507765 A JP2012507765 A JP 2012507765A JP 2012507765 A JP2012507765 A JP 2012507765A JP 2012525358 A5 JP2012525358 A5 JP 2012525358A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- medicament
- allopurinol
- induced
- hfsr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims description 13
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 claims description 11
- 229960003459 allopurinol Drugs 0.000 claims description 11
- 239000002147 L01XE04 - Sunitinib Substances 0.000 claims description 5
- 229960001796 sunitinib Drugs 0.000 claims description 5
- WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 claims description 5
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 claims description 4
- 239000005511 L01XE05 - Sorafenib Substances 0.000 claims description 4
- 229960003787 sorafenib Drugs 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- 206010040914 Skin reaction Diseases 0.000 claims 7
- 230000035483 skin reaction Effects 0.000 claims 7
- 231100000430 skin reaction Toxicity 0.000 claims 7
- 230000002265 prevention Effects 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229940043355 kinase inhibitor Drugs 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 2
- 238000011200 topical administration Methods 0.000 claims 2
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 239000008309 hydrophilic cream Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 208000024891 symptom Diseases 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21489409P | 2009-04-29 | 2009-04-29 | |
| EP09382058A EP2246057A1 (en) | 2009-04-29 | 2009-04-29 | Use of allopurinol for the treatment of hand foot skin reaction |
| EP09382058.7 | 2009-04-29 | ||
| US61/214,894 | 2009-04-29 | ||
| PCT/EP2010/055806 WO2010125143A1 (en) | 2009-04-29 | 2010-04-29 | Use of allopurinol for the treatment of hand foot skin reaction |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012525358A JP2012525358A (ja) | 2012-10-22 |
| JP2012525358A5 true JP2012525358A5 (enExample) | 2014-12-11 |
| JP6007101B2 JP6007101B2 (ja) | 2016-10-12 |
Family
ID=40897536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507765A Expired - Fee Related JP6007101B2 (ja) | 2009-04-29 | 2010-04-29 | 手足皮膚反応治療のためのアロプリノールの使用 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8623878B2 (enExample) |
| EP (2) | EP2246057A1 (enExample) |
| JP (1) | JP6007101B2 (enExample) |
| KR (1) | KR20120049848A (enExample) |
| CN (1) | CN102421436B (enExample) |
| AR (1) | AR076505A1 (enExample) |
| AU (2) | AU2010243594A1 (enExample) |
| BR (1) | BRPI1011971A2 (enExample) |
| CA (1) | CA2759085C (enExample) |
| DK (1) | DK2424538T3 (enExample) |
| ES (1) | ES2434366T3 (enExample) |
| HR (1) | HRP20131070T1 (enExample) |
| IL (1) | IL215831A (enExample) |
| ME (1) | ME01567B (enExample) |
| MX (1) | MX2011011529A (enExample) |
| NZ (1) | NZ595901A (enExample) |
| PL (1) | PL2424538T3 (enExample) |
| PT (1) | PT2424538E (enExample) |
| RS (1) | RS53005B (enExample) |
| RU (1) | RU2543325C2 (enExample) |
| SI (1) | SI2424538T1 (enExample) |
| WO (1) | WO2010125143A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013508295A (ja) | 2009-10-16 | 2013-03-07 | デューク・ユニヴァーシティ | 薬物誘発性手足症候群を治療するための組成物および方法 |
| CA2824933A1 (en) * | 2011-01-18 | 2012-07-26 | Vicus Therapeutics, Llc | Pharmaceutical compositions and methods for making and using them |
| TW201927292A (zh) | 2017-12-13 | 2019-07-16 | 大陸商上海小午醫藥科技有限公司 | 一種用於預防或治療與ｅｇｆｒ被抑制相關疾病的方法 |
| CN114028568A (zh) * | 2018-04-16 | 2022-02-11 | 上海岸阔医药科技有限公司 | 预防或治疗肿瘤疗法副作用的方法 |
| US20200046703A1 (en) * | 2018-08-09 | 2020-02-13 | Asymmetric Therapeutics, Llc | Compositions and methods for treatment of the side-effects associated with administration of therapeutic agents |
| US20250114362A1 (en) | 2022-01-05 | 2025-04-10 | Asymmetric Therapeutics, Llc | Methods and compositions for treatment of cutaneous proliferative disorders and other skin conditions |
| KR20250056445A (ko) * | 2023-10-19 | 2025-04-28 | (주) 수파드엘릭사 | 수족증후군 또는 수족피부반응의 예방 또는 치료용 약학 조성물 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE66147T1 (de) | 1987-02-13 | 1991-08-15 | Allergan Pharma | Verwendung von pteridinen und/oder purinen oder eines xanthinoxidase-hemmers zur herstellung eines arzneimittels zur behandlung von genetisch bedingten degenerativen netzhauterkrankungen. |
| GB9218711D0 (en) | 1992-09-04 | 1992-10-21 | Salim Aws S M | Skin cancer treatment |
| WO1994005293A1 (en) | 1992-09-04 | 1994-03-17 | Aws Shakir Mustafa Salim | Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol |
| JP3106817B2 (ja) | 1993-11-02 | 2000-11-06 | 富士電機株式会社 | 漏電遮断器 |
| US6284234B1 (en) | 1998-08-04 | 2001-09-04 | Johnson & Johnson Consumer Companies, Inc. | Topical delivery systems for active agents |
| US6060083A (en) | 1999-04-01 | 2000-05-09 | Topical Technologies, Inc. | Topical DMSO treatment for palmar-plantar erythrodysethesia |
| GB0013346D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
| DK1343492T3 (da) | 2000-11-22 | 2006-03-06 | Rxkinetix Inc | Behandling af mucositis |
| US7544348B2 (en) | 2001-02-15 | 2009-06-09 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| SE0100873D0 (sv) * | 2001-03-13 | 2001-03-13 | Astrazeneca Ab | Method of treatment |
| ES2325951T3 (es) | 2001-08-29 | 2009-09-25 | Pharmakodex Limited | Dispositivo de administracion topica. |
| KR100949318B1 (ko) | 2001-11-29 | 2010-03-23 | 사운드 파마슈티칼스 인코퍼레이티드 | 화학요법의 바람직하지 않은 작용을 개선하기 위한 방법과조성물 |
| DE10200578A1 (de) | 2002-01-09 | 2003-07-10 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme |
| US6979688B2 (en) | 2002-02-12 | 2005-12-27 | Ford John P | Treatment method against side-effects of chemotherapy |
| US20040214215A1 (en) | 2003-03-07 | 2004-10-28 | Yu Ruey J. | Bioavailability and improved delivery of alkaline pharmaceutical drugs |
| WO2004110380A2 (en) | 2003-06-11 | 2004-12-23 | Novacea, Inc. | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents |
| AU2004247109A1 (en) | 2003-06-11 | 2004-12-23 | Novacea, Inc | Treatment of cancer with active vitamin D compounds in combination with radiotherapeutic agents and treatments |
| US20050148908A1 (en) | 2003-12-24 | 2005-07-07 | Gregory Skover | Apparatus containing a receiving element for treatment of skin |
| JP4405326B2 (ja) | 2004-06-28 | 2010-01-27 | 株式会社東芝 | ランドリー機器 |
| ATE402709T1 (de) | 2004-09-17 | 2008-08-15 | Biomas Ltd | Neue tellurium-verbindungen und ihre verwendung als immunmodulatoren |
| HRP20100210T1 (hr) | 2006-06-01 | 2010-05-31 | Nobera Pharma | Upotreba alopurinola u liječenju eritrodisestezije dlana i stopala |
-
2009
- 2009-04-29 EP EP09382058A patent/EP2246057A1/en not_active Withdrawn
-
2010
- 2010-04-29 CN CN201080019054.2A patent/CN102421436B/zh not_active Expired - Fee Related
- 2010-04-29 PT PT107193146T patent/PT2424538E/pt unknown
- 2010-04-29 EP EP10719314.6A patent/EP2424538B1/en active Active
- 2010-04-29 JP JP2012507765A patent/JP6007101B2/ja not_active Expired - Fee Related
- 2010-04-29 SI SI201030402T patent/SI2424538T1/sl unknown
- 2010-04-29 DK DK10719314.6T patent/DK2424538T3/da active
- 2010-04-29 WO PCT/EP2010/055806 patent/WO2010125143A1/en not_active Ceased
- 2010-04-29 ME MEP-2013-127A patent/ME01567B/me unknown
- 2010-04-29 PL PL10719314T patent/PL2424538T3/pl unknown
- 2010-04-29 RS RS20130462A patent/RS53005B/sr unknown
- 2010-04-29 AU AU2010243594A patent/AU2010243594A1/en not_active Abandoned
- 2010-04-29 CA CA2759085A patent/CA2759085C/en not_active Expired - Fee Related
- 2010-04-29 HR HRP20131070AT patent/HRP20131070T1/hr unknown
- 2010-04-29 RU RU2011148355/15A patent/RU2543325C2/ru not_active IP Right Cessation
- 2010-04-29 BR BRPI1011971A patent/BRPI1011971A2/pt not_active IP Right Cessation
- 2010-04-29 NZ NZ595901A patent/NZ595901A/xx not_active IP Right Cessation
- 2010-04-29 MX MX2011011529A patent/MX2011011529A/es active IP Right Grant
- 2010-04-29 KR KR1020117028500A patent/KR20120049848A/ko not_active Abandoned
- 2010-04-29 ES ES10719314T patent/ES2434366T3/es active Active
- 2010-04-29 US US12/770,179 patent/US8623878B2/en not_active Expired - Fee Related
- 2010-04-30 AR ARP100101462A patent/AR076505A1/es unknown
-
2011
- 2011-10-23 IL IL215831A patent/IL215831A/en not_active IP Right Cessation
-
2013
- 2013-11-22 US US14/087,884 patent/US20140080845A1/en not_active Abandoned
-
2016
- 2016-09-14 AU AU2016228193A patent/AU2016228193A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014515373A5 (enExample) | ||
| JP2012525358A5 (enExample) | ||
| JP2014516942A5 (enExample) | ||
| JP2013516482A5 (enExample) | ||
| JP2009102342A5 (enExample) | ||
| JP2015528471A5 (enExample) | ||
| CA2883751A1 (en) | Methods of treating alzheimer's disease and pharmaceutical compositions thereof | |
| JP2017506624A5 (enExample) | ||
| RU2012133969A (ru) | Локальные трансдермальные композиции дексмедетомидина и способы их применения | |
| NZ714963A (en) | Compositions and methods for treating anemia | |
| RU2008152341A (ru) | Применение аллопуринола для лечения ладонно-подошвенной эритродизестезии | |
| JP2002528502A5 (enExample) | ||
| JP2017533972A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| RU2015102772A (ru) | Бензодиазелипы для мелкоклеточного рака легкого | |
| JP2015528501A5 (enExample) | ||
| CN105380941A (zh) | 苯酞类化合物药物用途及其医药组合物 | |
| JP2020500864A5 (enExample) | ||
| JP2018517759A5 (enExample) | ||
| CA2313270A1 (en) | Use of deferiprone in treating and preventing iron-induced cardiac disease | |
| JP2016505050A5 (enExample) | ||
| RU2013108390A (ru) | Фармацевтическая композиция для предотвращения периоперационной артериальной гипотензии у человека | |
| RU2011148355A (ru) | Применение аллопуринола для ладонно-родошвенного синдрома | |
| JP2011500589A5 (enExample) | ||
| CN110755432A (zh) | 烟酰胺在制备治疗手足皮肤反应制剂中的应用 |